Username or email address *
Lost your password?
Your Email (required)
Please prove you are human by selecting the Heart.
What Is Acute Lymphocytic Leukemia?
What Causes ALL?
What Are the Symptoms of ALL?
How Is ALL Diagnosed?
How Is ALL Treated?
What Is Acute Myelogenous Leukemia?
What Causes AML?
What Are the Symptoms of AML?
How Is AML Diagnosed?
How Is AML Treated?
What Is Chronic Lymphocytic Leukemia?
What Causes CLL?
What Are the Symptoms of CLL?
How Is CLL Diagnosed?
How Is CLL Treated?
What Is Chronic Myelogenous Leukaemia?
What Causes CML?
What Are the Symptoms of CML?
How Is CML Diagnosed?
How Is CML Treated?
What Is Hodgkin’s Lymphoma?
What Causes Hodgkin’s Lymphoma?
What Are the Symptoms of Hodgkin’s Lymphoma?
How Is Hodgkin’s Lymphoma Diagnosed?
How Is Hodgkin’s Lymphoma Treated?
What Is Non-Hodgkin’s Lymphoma NHL?
What Causes the NHL?
What Are the Symptoms of NHL?
How Is NHL Diagnosed?
How Is NHL Treated?
This genomic malignancy risk assessment evaluates your DNA for the following hereditary genetic mutations that may increase your risk of developing blood malignancy:
If you your genomic testing showed that you require referral to a specialist consultant, we will provide you, at no cost to you, with a referral letter to a specialist consultant from our wide network of independent doctors all around the United Kingdom. Our referral letter will give the specialist consultant all the needed details to take care of your clinical case, according to the results of the genomic tests you have had at Genomic Medicine UK.
FREQUENTLY ASKED QUESTIONS ABOUT THE GENOMIC RISK ASSESSMENT FOR HEREDITARY MALIGNANCIES (CANCERS)
BLOOD MALIGNANCIES GENOMIC RISK ASSESSMENT
If you prefer to visit Genomic Medicine UK instead of having your genomic test by post, as explained above, you are most welcome to book a suitable appointment for you to visit our premises in central London where our fully trained and friendly staff will be more than happy to take your DNA sample in one of our outpatients’ clinics in Harley Street.
Innovative genomic DNA testing to investigate if you are at a higher risk of developing blood malignancy due to certain hereditary mutations in your genes.